Octreotide treatment of hepatocellular carcinoma
- PMID: 12540801
- DOI: 10.1053/jhep.2003.50026
Octreotide treatment of hepatocellular carcinoma
Comment on
-
A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.Hepatology. 2002 Sep;36(3):687-91. doi: 10.1053/jhep.2002.35071. Hepatology. 2002. PMID: 12198662 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical